These medications quickly control acute asthma attacks.
Beta2-agonists do not reduce inflammation or airway responsiveness but serve as bronchodilators, relaxing and opening constricted airways during an acute asthma attack. They are used alone only for patients with mild and intermittent asthma. Patients with more severe cases should use them in combination with other drugs.
Tick...tick...tick...Do you hear it? That's the sound of the clock ticking down to December 31, 2008 - the day some of the inhaled... Read more »
Are you currently using an albuterol metered dose inhaler (MDI) as your quick relief or rescue inhaler? If so, expect your treatment plan... Read more »
In response to reader concerns, I would like to revisit the issue of the efficacy of the new, ‘environmentally friendly'... Read more »
Last month, Californians suffered wildfire tragedies that led to the evacuation of nearly a million people. The fires took lives and... Read more »
An Overview In accordance with an international agreement to reduce ozone-depleting propellants, manufacturers of many inhalers have... Read more »
At the end of 2008, asthma inhalers that contain the ozone-harming chemicals called chlorofluorocarbons (CFCs) will no longer be sold, but the U.S.... Read more »
Asthma inhalers containing environmentally harmful chlorofluorocarbon (CFC) propellants are being replaced by manufacturers to conform to new FDA... Read more »
A review of clinical trials has shown that bronchodilators that contain inhaled beta-agonists like salmeterol (Advair) and albuterol increased the... Read more »
Asthma is a chronic inflammatory condition that causes the airways (bronchi) to produce excess mucus and close, making breathing difficult.... Read more »
An advisory panel has recommended that the FDA remove the "essential use" status of nonprescription inhalers that use ozone-depleting... Read more »